Literature DB >> 2996374

Cellular differentiation in ovarian sex-cord-stromal and germ-cell tumors studied with antibodies to intermediate-filament proteins.

M Miettinen, T Wahlstrom, I Virtanen, A Talerman, C Astengo-Osuna.   

Abstract

Seventy ovarian sex-cord-stromal and germ-cell tumors were immunohistochemically studied for the presence of intermediate-filament proteins of different types used as markers for cellular differentiation. Cells of ovarian granulosa-cell tumors constantly expressed vimentin and appeared to lack cytokeratin. Two tumors previously classified as granulosa-cell tumors were reclassified as poorly differentiated "common" epithelial tumors based on their cytokeratin positivity, vimentin negativity, and morphologic features. Dysgerminomas and Leydig-cell tumors showed only vimentin positivity. Tubular structures in androblastomas, which are considered to represent Sertoli-cell differentiation, were cytokeratin positive, and thus differed from the majority of normal Sertoli cells that are known to express vimentin and not cytokeratin. Embryonal carcinomas, choriocarcinomas, and endodermal sinus tumors showed cytokeratin positivity in the neoplastic cells whereas vimentin was observed in the stromal cells. In immature teratomas, epithelial differentiation was demonstrated with cytokeratin antibodies, and neural and glial differentiation was also frequently demonstrated by immunostaining with antibodies to neurofilaments and glial fibrillary acidic protein. The results show that antibodies to intermediate filaments can be used in the differential diagnosis between ovarian epithelial and nonepithelial tumors, and they provide a very accurate additional method to characterize the cellular differentiation of ovarian neoplasms.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2996374     DOI: 10.1097/00000478-198509000-00003

Source DB:  PubMed          Journal:  Am J Surg Pathol        ISSN: 0147-5185            Impact factor:   6.394


  9 in total

1.  Case report: malignant Sertoli cell tumor of the testis in an adult.

Authors:  A Demir; F F Onol; L Türkeri
Journal:  Int Urol Nephrol       Date:  2003       Impact factor: 2.370

2.  Immunohistochemical differentiation between ovarian granulosa cell tumors and ovarian carcinomas.

Authors:  G Gitsch; P Kohlberger; E Hanzal; H Kölbl; G Breitenecker
Journal:  Arch Gynecol Obstet       Date:  1991       Impact factor: 2.344

3.  Use of immunohistochemical staining panel for characterisation of ovarian neoplasms.

Authors:  P Ashorn; M Helle; H Helin; R Ashorn; K Krohn
Journal:  J Clin Pathol       Date:  1988-01       Impact factor: 3.411

4.  Testicular sex cord stromal tumour with granulosa cell differentiation: detection of steroid hormone receptors as a possible basis for tumour development and therapeutic management.

Authors:  W Düe; K P Dieckmann; G Niedobitek; G Bornhöft; V Loy; H Stein
Journal:  J Clin Pathol       Date:  1990-09       Impact factor: 3.411

5.  Immunohistochemistry of ovarian granulosa cell tumours. The value of tissue specific proteins and tumour markers.

Authors:  S Chadha; T H van der Kwast
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1989

Review 6.  [Endocrine-active tumors of the ovary].

Authors:  H-E Stegner; Th Löning
Journal:  Pathologe       Date:  2003-06-19       Impact factor: 1.011

7.  Testicular sex cord-stromal lesions: immunohistochemical analysis of cytokeratin, vimentin and steroidogenic enzymes.

Authors:  H Sasano; N Nakashima; O Matsuzaki; H Kato; S Aizawa; N Sasano; H Nagura
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1992

8.  Expression of cytokeratins in granulosa cell tumors and ovarian carcinomas.

Authors:  G Gitsch; P Kohlberger; A Steiner; B Neumeister; G Breitenecker
Journal:  Arch Gynecol Obstet       Date:  1992       Impact factor: 2.344

9.  Desmosomal plaque-associated vimentin filaments in human ovarian granulosa cell tumors of various histologic patterns.

Authors:  B Czernobilsky; R Moll; G Leppien; G Schweikhart; W W Franke
Journal:  Am J Pathol       Date:  1987-03       Impact factor: 4.307

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.